lysosomal acid lipase deficiency

Search with Google Search with Bing
Information
Disease name
lysosomal acid lipase deficiency
Disease ID
DOID:0080217
Description
"A lipid storage disease characterized by dyslipidemia and accumulation of cholesteryl esters and triglycerides within various organs that has_material_basis_in homozygous or compound heterozygous mutation in the LIPA gene on chromosome 10q23.31." [url:https\://medlineplus.gov/genetics/condition/lysosomal-acid-lipase-deficiency/, url:https\://www.ncbi.nlm.nih.gov/books/NBK395569/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01757184 Completed Phase 3 Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency January 22, 2013 December 11, 2018
NCT02112994 Completed Phase 2 Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency June 24, 2014 December 28, 2017
NCT01371825 Completed Phase 2/Phase 3 Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency May 4, 2011 January 3, 2018
NCT01488097 Completed Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency December 12, 2011 June 21, 2017
NCT01528917 Completed An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype June 2011 May 2013
NCT01358370 Completed A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype November 2010 March 2013
NCT01307098 Completed Phase 1/Phase 2 Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency April 25, 2011 January 6, 2012
NCT05368038 Enrolling by invitation ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program May 10, 2021 July 31, 2026
NCT03655223 Enrolling by invitation Early Check: Expanded Screening in Newborns October 15, 2018 December 31, 2025
NCT02376751 No longer available An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
NCT05687474 Recruiting Baby Detect : Genomic Newborn Screening September 1, 2022 August 31, 2025
NCT01633489 Recruiting Lysosomal Acid Lipase (LAL) Deficiency Registry December 31, 2012 June 30, 2029
NCT03984149 Recruiting Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) September 1, 2017 July 1, 2023
NCT02345421 Terminated A Study to Identify and Characterize LAL-D Patients in High-risk Populations December 2014 October 2015
NCT02193867 Terminated Phase 2 Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency June 6, 2014 October 30, 2018
NCT02926872 Terminated Screening for Lysosomal Acid Lipase Deficiency November 2016 June 5, 2017
NCT03564002 Unknown status Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity October 1, 2016 December 31, 2022
NCT01716728 Unknown status N/A Identification of Undiagnosed Lysosomal Acid Lipase Deficiency August 2012
Disase is a (Disease Ontology)
DOID:9455
Cross Reference ID (Disease Ontology)
GARD:12097
Cross Reference ID (Disease Ontology)
ICD10CM:E75.5
Cross Reference ID (Disease Ontology)
MIM:PS278000
Cross Reference ID (Disease Ontology)
ORDO:275761
Cross Reference ID (Disease Ontology)
UMLS_CUI:C5574740
Exact Synonym (Disease Ontology)
LAL deficiency
Exact Synonym (Disease Ontology)
LAL-D
OrphaNumber from OrphaNet (Orphanet)
275761